Adolescent Depression

Alternative treatments for adolescent depression are critically needed. The remission rate with anti-depressants and cognitive therapy remains at approximately 35-50% which leaves millions of teenagers with untreated depression. The research on TMS for adolescents is very promising. Currently TMS has an FDA indication for 18 years and older. Recent trials indicate that TMS is equally safe for adolescents and it may be more effective for teenagers than adults. Zhang and his colleagues published an article in 2018 with preliminary evidence that TMS may be used for acute depression and anxiety in adolescents (Zhang et al 2018).

Safety of Noninvasive Brain Stimulation in Children and Adolescents
Krishnan, Chandramouli et al. Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation, Volume 8, Issue 1, 76 – 87